A Morphological Study in Volleyball Athletes With Cronic Ankle Instability

Sponsor
Hacettepe University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05746663
Collaborator
(none)
24
21.8

Study Details

Study Description

Brief Summary

The former purpose of this study to investigate the effect of transverse abdominis, lumbar multifidus, vastus lateralis, lateral gastrocnemius, anterior talofibular ligament of morphology on explosive power and balance performance in cronic ankle instability with volleyball players. The latter purpose of this study to determine morphological characteristics volleyball players with and without cronic ankle insatbility of trunk muscle morphology, field tests and the muscle morphology features between the body affected and unaffected sides whose those with chronic ankle instability.This study was designed as a cross-sectional. Twelve volleyball players with chronic ankle instability who meet the criteria determined by the ankle consortium will be included in study group. Twelve asymptomatic volleyball players who have been training at least three days a week for at least one year will be include in the control group. They will consist of 24 volleyball players between 14-35 years of age.Morphological characteristics of anterior talofibular ligament, transverse abdominis, lumbar multifidus, vastus lateralis, lateral gastrocnemius will be evaluated via ultrasound, explosive power with squat jump, counter movement jump and balance performance by Y-Balance Test. Trunk muscle morphology, core stabilization, explosive power, balance performance will have been compered in volleyball players with and without chronic ankle instability. The effects of morphological features on explosive power and balance performance will have been determined. It is anticipated that by determining the parameters that can be affected by instability with volleyball players, it will guide the professionals working in the field, countribute to treatment and preventive treatment programs.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
24 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Kronik Ayak Bileği İnstabilitesi Olan Voleybolcularda Denge ve Patlayıcı Güç Üzerine Morfolojik Bir Çalışma
Anticipated Study Start Date :
Feb 20, 2023
Anticipated Primary Completion Date :
Jun 14, 2023
Anticipated Study Completion Date :
Dec 14, 2024

Outcome Measures

Primary Outcome Measures

  1. Muscle morphology [1 day]

    Morphological characteristics of anterior talofibular ligament, transverse abdominis, lumbar multifidus, vastus lateralis, lateral gastrocnemius will be evaluated via ultrasound imaging

  2. Balance [1 day]

    Y Balance Test

  3. Expolsive Power [1 day]

    Squat jump, Countermovement jump Test

  4. Core stability [1 day]

    Sharmannn's Core Stability Tet

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 30 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Inclusion for the CAI group followed the International Ankle Consortium guidelines.

Criteria for inclusion in the control group:

To train for 1 hour at least 3 days a week for at least 1 year, Cumberland Ankle Instability Instrument (CAIT) score of 25 or higher, To have a Tegner activity level of 4 and above, It is not to have a systemic disease

Exclusion Criteria:

The patient will be excluded from the study in the event of the presence of at least one of the following criteria:

Having undergone ankle, knee, hip surgery, Having bilateral ankle instability, Having suffered a known musculoskeletal injury of the hip Having suffered an ankle sprain during the evaluation process

Criteria for exclusion from the study:

Withdraw to any period

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Hacettepe University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aynur Demirel, PT, PhD, Assoc. Prof., Hacettepe University
ClinicalTrials.gov Identifier:
NCT05746663
Other Study ID Numbers:
  • GO 22/885
First Posted:
Feb 28, 2023
Last Update Posted:
Feb 28, 2023
Last Verified:
Feb 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 28, 2023